{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:13:51Z","timestamp":1758053631074,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.contraception.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T01:48:09Z","timestamp":1561340889000},"page":"288-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increasing body mass index or weight does not appear to influence the association between efavirenz-based antiretroviral therapy and implant effectiveness among HIV-positive women in western Kenya"],"prefix":"10.1016","volume":"100","author":[{"given":"Rena C.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Jakait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Yiannoutsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricianah","family":"Onono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara K.","family":"Wools-Kaloustian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2019.06.011_bb0005","unstructured":"(UNAIDS) JUNPoHA. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: UNAIDS; 2013."},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2019.06.011_bb0010","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/QAD.0000000000000035","article-title":"Integration of family planning services into HIV care and treatment in Kenya: a cluster-randomized trial","volume":"27","author":"Grossman","year":"2013","journal-title":"AIDS."},{"key":"10.1016\/j.contraception.2019.06.011_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.contraception.2012.10.004","article-title":"Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia","volume":"88","author":"Khu","year":"2013","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2019.06.011_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e31827ee19c","article-title":"Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia","volume":"63","author":"Wall","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"year":"2015","series-title":"Geneva","author":"WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","key":"10.1016\/j.contraception.2019.06.011_bb0025"},{"key":"10.1016\/j.contraception.2019.06.011_bb0030","doi-asserted-by":"crossref","unstructured":"Robinson JA, Jamshidi R, Burke AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:890160.","DOI":"10.1155\/2012\/890160"},{"key":"10.1016\/j.contraception.2019.06.011_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2013.772579","article-title":"Drug interactions between antiretrovirals and hormonal contraceptives","volume":"9","author":"Tseng","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"10.1016\/j.contraception.2019.06.011_bb0040","doi-asserted-by":"crossref","unstructured":"Patel RC, Onono M, Gandhi M, et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. The Lancet HIV. 2015;2:e474-e82.","DOI":"10.1016\/S2352-3018(15)00184-8"},{"key":"10.1016\/j.contraception.2019.06.011_bb0045","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/QAD.0000000000000177","article-title":"Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies","volume":"28","author":"Perry","year":"2014","journal-title":"AIDS."},{"issue":"6","key":"10.1016\/j.contraception.2019.06.011_bb0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/cid\/civ1001","article-title":"Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48\u202fweeks","volume":"62","author":"Scarsi","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.contraception.2019.06.011_bb0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/QAI.0000000000000189","article-title":"Effect of antiretroviral therapy including lopinavir\/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women","volume":"66","author":"Vieira","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.contraception.2019.06.011_bb0060","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/QAD.0000000000001591","article-title":"Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy","volume":"31","author":"Chappell","year":"2017","journal-title":"AIDS."},{"key":"10.1016\/j.contraception.2019.06.011_bb0065","first-page":"13","article-title":"Interaction between etonogestrel-releaseing implant and three antiretroviral regimens. Conference on Retroviruses and Opportunistic Infections (CROI). Seatte","author":"Kreitchmann","year":"2017","journal-title":"WAFebruary"},{"key":"10.1016\/j.contraception.2019.06.011_bb0070","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.fertnstert.2016.07.1094","article-title":"Hormonal contraception and obesity","volume":"106","author":"Simmons","year":"2016","journal-title":"Fertil Steril."},{"issue":"8","key":"10.1016\/j.contraception.2019.06.011_bb0075","article-title":"Hormonal contraceptives for contraception in overweight or obese women","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.contraception.2019.06.011_bb0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bpobgyn.2014.10.005","article-title":"Contraception and sexual health in obese women","volume":"29","author":"Simmons","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.contraception.2019.06.011_bb0085","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep."},{"year":"2015","series-title":"Medical eligibility criteria for contraceptive use (MEC)","author":"Research DoRHa","key":"10.1016\/j.contraception.2019.06.011_bb0090"},{"key":"10.1016\/j.contraception.2019.06.011_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.contraception.2019.06.011_bb0100","unstructured":"Council P. New drug application 20-544: \u201cNorplant II\u201d levonorgestrel implants (Jadelle). 2002."},{"key":"10.1016\/j.contraception.2019.06.011_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.contraception.2019.06.011_bb0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000690","article-title":"Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration","volume":"125","author":"McNicholas","year":"2015","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.contraception.2019.06.011_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2009.10.013","article-title":"Sino-implant (II) \u2014 a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception."},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2019.06.011_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"10.1016\/j.contraception.2019.06.011_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.contraception.2004.10.005","article-title":"Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia","volume":"71","author":"Harrison-Woolrych","year":"2005","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2019.06.011_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419302136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782419302136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:14:30Z","timestamp":1757880870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782419302136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0010782419302136"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2019.06.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing body mass index or weight does not appear to influence the association between efavirenz-based antiretroviral therapy and implant effectiveness among HIV-positive women in western Kenya","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}